ProMIS Neurosciences, Inc.

NASDAQ:PMN

Biotechnology

Healthcare
$11.08 -0.14%

-$0.02 today

Market cap
$99.36M
Beta
-0.22
P/E (TTM)
-0.6
EPS (TTM)
-$4.62
52W Low $6.27High $27.40

Volume 0.13M

Average 0.07M

Balance Sheet

Inspect the capital base behind the business.

Assets

$9.18M

FY 2025 · Annual

-51.4% YoY

Liabilities

$10.44M

FY 2025 · Annual

+330.9% YoY

Equity

-$1.26M

FY 2025 · Annual

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · USD
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Cash & Equivalents21.43M10.69M12.6M13.29M6.12M
Short-term Investments50.69K79.89K32.36K33.05K33.75K
Net Receivables0078.64K78.03K36.52K
Inventory00000
Other Current Assets768.78K768.19K228.85K47.28K70.48K
Total Current Assets22.4M12.56M13.62M18.91M9.18M
Property, Plant & Equipment (Net)5.91K584000
Goodwill00000
Intangible Assets34.92K37.91K000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets40.83K38.49K000
Total Assets22.44M12.6M13.62M18.91M9.18M
Account Payables517.17K5.41M7.84M1.74M2.54M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities00518.7K38.33K79.75K
Total Current Liabilities1.17M11.67M9.35M2.22M10.41M
Long-term Debt4.94M0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities9.17M3.38M516.19K204.86K29.18K
Total Non-current Liabilities14.11M3.38M516.19K204.86K29.18K
Total Liabilities15.28M15.05M9.87M2.42M10.44M
Common Stock00000
Retained Earnings(78.64M)(146M)(93.47M)(90.69M)(130.41M)
Accumulated OCI(237.63K)(355.42K)(371.18K)(371.18K)(371.18K)
Other Stockholders Equity0946000
Minority Interest00000
Total Equity7.16M(2.45M)3.75M16.49M(1.26M)
Total Debt4.94M0000
Net Debt(16.49M)(10.69M)(12.6M)(13.29M)(6.12M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$53.4M
Short-term Investments$33.8K
Other Current$3.2M
Total Current Assets$56.7M
Total Assets$56.7M

Analysis

Selected assets total $56.7M for Latest. The largest visible component is Cash & Equivalents at $53.4M, about 94.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 6, 2026
3Initial statement of beneficial ownershipOct 6, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 13, 2026
8-KCurrent reportAug 13, 2026

How much cash does PMN have?

ProMIS Neurosciences, Inc. (PMN) reported $6.12M in cash and equivalents in fiscal 2025.

How much debt does PMN carry?

ProMIS Neurosciences, Inc. (PMN) reported $0.00 of total debt, with net debt of -$6.12M.